{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T01:25:46Z","timestamp":1772155546253,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.micpath.2018.05.005","type":"journal-article","created":{"date-parts":[[2018,5,6]],"date-time":"2018-05-06T09:46:56Z","timestamp":1525600016000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae"],"prefix":"10.1016","volume":"120","author":[{"given":"Behnam","family":"Hashemi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Rafiei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Pormohammad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Ahanjan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Moghadaszadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Rashidian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2018.05.005_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/jac\/46.2.223","article-title":"Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in The Netherlands","volume":"46","author":"Goettsch","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2018.05.005_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1128\/CMR.11.4.589","article-title":"Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors","volume":"11","author":"Podschun","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.05.005_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJM199611073351907","article-title":"Antimicrobial-drug resistance","volume":"335","author":"Gold","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.micpath.2018.05.005_bib4","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and dissemination of \u03b2-lactamases accelerated by generations of \u03b2-lactam antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.micpath.2018.05.005_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/601630","article-title":"Molecular analysis of ciprofloxacin resistance mechanisms in Malaysian ESBL-producing Klebsiella pneumoniae isolates and development of mismatch amplification mutation assays (MAMA) for rapid detection of gyrA and parC mutations","author":"Al-Marzooq","year":"2014","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.micpath.2018.05.005_bib6","first-page":"42","article-title":"Use of a MAMA-PCR method to detect gyrA mutations in nalidixic acid resistant clinical isolates of Escherichia coli","volume":"37","author":"Karami","year":"2008","journal-title":"Iran J. Public Health"},{"key":"10.1016\/j.micpath.2018.05.005_bib7","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijantimicag.2010.12.013","article-title":"Detection of novel gyrA mutations in nalidixic acid-resistant isolates of Salmonella enterica from patients with diarrhea","volume":"37","author":"Hamidian","year":"2011","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2018.05.005_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tube.2014.08.012","article-title":"Gene mutations in Mycobacterium tuberculosis: multidrug-resistant TB as an emerging global public health crisis","volume":"95","author":"Mishra","year":"2015","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2018.05.005_bib9","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.gendis.2016.03.005","article-title":"ESR1 mutations: pi\u00e8ce de r\u00e9sistance","volume":"3","author":"Button","year":"2016","journal-title":"Genes Dis"},{"key":"10.1016\/j.micpath.2018.05.005_bib10","first-page":"126","volume":"vol. 12","author":"Foroni","year":"2017"},{"key":"10.1016\/j.micpath.2018.05.005_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.11.1.142","article-title":"Diarrheagenic Escherichia coli","volume":"11","author":"Nataro","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.05.005_bib12","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1046\/j.1365-2958.2002.02952.x","article-title":"Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules","volume":"44","author":"Kenny","year":"2002","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.micpath.2018.05.005_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nrmicro818","article-title":"Pathogenic escherichia coli","volume":"2","author":"Kaper","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.micpath.2018.05.005_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/mr.60.1.167-215.1996","article-title":"Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion","volume":"60","author":"Sears","year":"1996","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.micpath.2018.05.005_bib15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.femsle.2005.08.028","article-title":"Escherichia coli mediated urinarytract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?","volume":"252","author":"Marrs","year":"2005","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Lett."},{"key":"10.1016\/j.micpath.2018.05.005_bib16","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-111-11-906","article-title":"Urinary tract infections in women: diagnosis and treatment","volume":"111","author":"Johnson","year":"1989","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.micpath.2018.05.005_bib17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0255-0857(21)02884-X","article-title":"Extended spectrum-lactamases (ESBL)-An emerging threat to clinical therapeutics","volume":"22","author":"Chaudhary","year":"2004","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.micpath.2018.05.005_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vetmic.2005.01.021","article-title":"Antimicrobial susceptibility and molecular characterization of avian pathogenic Escherichia coli isolates","volume":"107","author":"Zhao","year":"2005","journal-title":"Vet. Microbiol."},{"key":"10.1016\/j.micpath.2018.05.005_bib19","series-title":"The effect of mutations in type II topoisomerases on fluoroquinolone resistance in clinical canine urine Escherichia coli isolates","author":"Behringer","year":"2011"},{"key":"10.1016\/j.micpath.2018.05.005_bib20","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.resmic.2004.02.009","article-title":"Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum \u03b2-lactamases","volume":"155","author":"Shah","year":"2004","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.micpath.2018.05.005_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijantimicag.2006.01.007","article-title":"First description of CTX-M \u03b2-lactamase-producing clinical Escherichia coli isolates from Egypt","volume":"27","author":"Mohammad Al-Agamy","year":"2006","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.micpath.2018.05.005_bib22","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1093\/jac\/dkg168","article-title":"Mutations in gyrA and parC genes in nalidixic acid-resistant Escherichia coli strains from food products, humans and animals","volume":"51","author":"S\u00e1enz","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2018.05.005_bib23","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jac\/49.3.549","article-title":"Use of a rapid mismatch PCR method to detect gyrA and parC mutations in ciprofloxacin-resistant clinical isolates of Escherichia coli","volume":"49","author":"Zhi Qiang","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.micpath.2018.05.005_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mrrev.2016.04.009","article-title":"Mutations of myelodysplastic syndromes (MDS): an update","volume":"769","author":"Ganguly","year":"2016","journal-title":"Mutat. Res. Rev. Mutat. Res."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018306223?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401018306223?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:21:41Z","timestamp":1760109701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401018306223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":24,"alternative-id":["S0882401018306223"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2018.05.005","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The comparison of MAMA PCR and SSCP PCR to study chromosomal resistance against Ciprofloxacin and Nalidixic acid in Escherichia coli and Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2018.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}